Moreover, the high expression of RHOJ demonstrated a significant correlation with diverse clinical features linked to cancer metastasis and disease advancement, highlighting its worth as a crucial biomarker for disease severity and tumor aggression. This evidence concerns the gene RHOJ and cancer.